Conduction of IPO has been planned with further entry to the Hong Kong Stock Exchange by 2020.
We guarantee our partners:
- Prompt establishment of modern high-tech drug production, equipped with international standards;
- High quality products that underwent three-factor verification before sales launch;
- Equally fast delivery for both large and small lots of products;
- Convenient individual conditions of cooperation;
We invite you to become our partner!
|Name||Koru Pharmaceuticals Co., Ltd|
|Revenues in 2016||7 million USD|
|Revenues in 2017||15 million USD|
|Work geography||Over 40 countries|
|Number of labs||3|
|Number of suppliers||220|
|Number of products||Over 300|
Apply now and our manager will get in touch with you shortly.
* — must be filled in.